Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Disease    crawled date : 2021 - 09 - 09    save search

Worldwide Root Canal Industry to 2028 - Rising Dental Disease Prevalence is Driving Growth
Published: 2021-09-09 (Crawled : 15:00) - prnewswire.com
NVST | $20.28 0.3% 0.0% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 1.89% C: 0.86%

disease growth
Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher DiseaseClinical trial site initiation for Gaucher disease Type 1 on track by year end
Published: 2021-09-09 (Crawled : 15:00) - biospace.com/
FRLN | $6.48 0.0% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.61% C: -0.25%

disease treatment orphan drug drug trial pons designation
Vascular Access Devices Market Gains from Growing Number of Surgeries Related to Vascular Diseases, Demand for Minimally Invasive Procedures to Extend Opportunities, Says TMR
Published: 2021-09-09 (Crawled : 14:00) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.53% C: -1.29%

disease growing device
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
WVE | $5.01 -1.38% -1.4% 430K twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 4.48% C: 2.7%

huntington disease phase 1 life science trial phase 1b phase 2b huntington’s disease
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
DBTX | $4.91 -0.81% -0.2% 0 twitter stocktwits trandingview |
Health Technology
| | O: 4.66% H: 3.72% C: -2.85%

disease treatment rare pediatric disease designation orphan drug drug hearing loss designation rare
AGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study
Published: 2021-09-09 (Crawled : 12:15) - agtc.com
OTIC | $0.077 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.33% C: -0.67%
AGTC | News | $0.3936 1.23% 0.0% twitter stocktwits trandingview |
Health Technology
| | O: 1.49% H: 2.35% C: -0.29%

disease clinical trials trials trial conference rare
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.